Inside-Filings
Projekt anfragen

Lb Pharmaceuticals Inc (LBRX)

LB PHARMACEUTICALS INC
Healthcare · Biotechnology
TickerLBRXBörseNasdaq
ISINUS50180M1080CIK0001691082
28,42
Schluss · 12.06.2026
1T−0,4 %1W−0,4 %1M−12,0 %3M+10,7 %6M+48,6 %
GCS 33 → +0,0
TSI -4,7 · -5,5 ▲ 08.06.
Insider ▲ 12.09.25· 277T
PDF

Glück Conviction Score™ ⓘ

LBRX LB PHARMACEUTICALS INC
Conviction Score
33
Schwach
Effektiv: Schwach Niedrig
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
59,0
16 neu, 30 erhöht, 78,3M $ netto
Aktivist
36,8
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)

Score-Verlauf (90 Tage)

Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.

Kursverlauf (12 Monate)

Technische Indikatoren

52.5
Technical-Score: 52.5 / 100 (informativ, keine Anlageempfehlung)
Bullisch-Anteil 20 % — 2 bullisch / 1 bärisch / 7 neutral

Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).

IndikatorSignalGewichtWertDetailBeitrag
Kurs vs SMA50Bärisch10 %29.22-2.8 % vs SMA50
EMA20 vs EMA50Bullisch5 %28.73EMA50: 28.35
MACD-HistogrammBullisch10 %0.047Bullisch
RSI(14)Neutral10 %47.6Neutral (30–70)
Stoch %K(14)Neutral5 %50.6Neutral
ADX(14)+DINeutral10 %16.5+DI: 19.7 / −DI: 17.0
Z-Score(60)Neutral5 %0.02In Range
52W-PositionNeutral5 %75.6 %Hoch 32.88 / Tief 14.61
Bollinger(20,2σ)Neutral5 %56.6 %Upper 29.57 / Mid 28.25 / Lower 26.92
LinReg-Slope(60)Neutral10 %+0.0793R²=0.24 / annualisiert +70.5 %

Insider-Transaktionen (12 Monate) ⓘ

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2025-09-12Nussbaum RanDirectorOpen Market Purchase1.000.00015,0015.000.000,00+120,0%
2025-09-12Vida Ventures GP III, L.L.C.10% OwnerOpen Market Purchase76715,0011.505,00+0,1%
2025-09-12Vida Ventures GP III, L.L.C.10% OwnerOpen Market Purchase332.56615,004.988.490,00+39,9%
2025-09-12Pontifax Management 4 G.P. (2015) Ltd.10% OwnerOpen Market Purchase1.000.00015,0015.000.000,00+120,0%
2025-09-12Deep Track Biotechnology Master Fund, Ltd.10% OwnerOpen Market Purchase666.66615,009.999.990,00+80,0%
2025-09-12Deep Track Biotechnology Master Fund, Ltd.10% OwnerOpen Market Purchase2.000.00015,0030.000.000,00+240,0%

Fondsaktivität (Vorquartalsvergleich) ⓘ

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
Deep Track Capital, LP3.352.8043.352.804082.680.147Unverändert0,0%
BlackRock, Inc.2.470.8452.238.934231.91160.931.038Aufgestockt+10,4%
RA CAPITAL MANAGEMENT, L.P.2.208.6042.208.604054.464.175Unverändert0,0%
TCG Crossover Management, LLC1.839.4891.745.01594.47445.279.611Aufgestockt+5,4%
Commodore Capital LP1.500.0001.500.000036.990.000Unverändert0,0%
JPMORGAN CHASE & CO1.611.48201.611.48235.871.589Neu+100,0%
Caligan Partners LP1.438.07001.438.07034.628.726Neu+100,0%
Spruce Street Capital LP1.376.1591.005.593370.56633.644.866Aufgestockt+36,9%
Trails Edge Capital Partners, LP1.319.3621.395.608-76.24632.535.467Reduziert-5,5%
Nantahala Capital Management, LLC1.052.894675.000377.89425.964.366Aufgestockt+56,0%
VANGUARD GROUP INC1.112.97801.112.97824.774.891Neu+100,0%
BALYASNY ASSET MANAGEMENT L.P.923.694896.80626.88822.778.294Aufgestockt+3,0%
Logos Global Management LP915.0001.200.000-285.00022.563.900Reduziert-23,8%
VANGUARD CAPITAL MANAGEMENT LLC894.6530894.65322.062.143Neu+100,0%
Alyeska Investment Group, L.P.863.947675.000188.94721.283.499Aufgestockt+28,0%
Vivo Capital, LLC800.000800.000019.728.000Unverändert0,0%
Nan Fung Group Holdings Ltd630.657300.000330.65715.552.002Aufgestockt+110,2%
JENNISON ASSOCIATES LLC538.216821.852-283.63613.272.406Reduziert-34,5%
GEODE CAPITAL MANAGEMENT, LLC518.228441.45476.77412.783.099Aufgestockt+17,4%
STATE STREET CORP504.373250.030254.34312.437.838Aufgestockt+101,7%
CITADEL ADVISORS LLC416.906407.6689.23810.280.902Aufgestockt+2,3%
GOLDMAN SACHS GROUP INC363.799303.11560.6848.971.283Aufgestockt+20,0%
GREAT POINT PARTNERS LLC300.0000300.0007.398.000Neu+100,0%
FMR LLC222.508221.8656435.487.057Aufgestockt+0,3%
BAKER BROS. ADVISORS LP200.000200.00004.932.000Unverändert0,0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC186.095177.6168.4794.589.103Aufgestockt+4,8%
HighVista Strategies LLC173.595140.10733.4884.280.853Aufgestockt+23,9%
NORTHERN TRUST CORP154.398143.96610.4323.807.455Aufgestockt+7,2%
Integral Health Asset Management, LLC150.000100.00050.0003.699.000Aufgestockt+50,0%
UBS Group AG137.93250.71387.2193.401.404Aufgestockt+172,0%
MILLENNIUM MANAGEMENT LLC136.9660136.9663.377.582Neu+100,0%
AMERIPRISE FINANCIAL INC108.307193.544-85.2372.670.851Reduziert-44,0%
Eversept Partners, LP100.1980100.1982.470.883Neu+100,0%
Longbow Finance SA82.336082.3361.832.799Neu+100,0%
Russell Investments Group, Ltd.72.0671.52570.5421.777.169Aufgestockt+4625,7%
Boxer Capital Management, LLC70.00070.00001.726.200Unverändert0,0%
JANUS HENDERSON GROUP PLC65.429065.4291.613.479Neu+100,0%
WELLINGTON MANAGEMENT GROUP LLP52.640052.6401.298.103Neu+100,0%
STEMPOINT CAPITAL LP50.000050.0001.233.000Neu+100,0%
MORGAN STANLEY47.28024.64122.6391.165.925Aufgestockt+91,9%
ACUTA CAPITAL PARTNERS, LLC28.91930.000-1.081713.143Reduziert-3,6%
JANE STREET GROUP, LLC31.733031.733706.377Neu+100,0%
Calamos Advisors LLC24.063024.063593.394Neu+100,0%
Nuveen, LLC22.96622.9660566.342Unverändert0,0%
Focus Partners Wealth19.81520.095-280488.638Reduziert-1,4%
NORGES BANK20.000020.000445.200Neu+100,0%
XTX Topco Ltd19.121019.121425.633Neu+100,0%
RHUMBLINE ADVISERS17.10316.283820421.753Aufgestockt+5,0%
BANK OF AMERICA CORP /DE/16.61843.758-27.140409.800Reduziert-62,0%
MARSHALL WACE, LLP18.014018.014400.992Neu+100,0%

Top-Fondshalter (Stand: 31.03.2026) ⓘ

FondsAnteileVorquartal (Stk)ΔWert (USD)Anteil (%)
Deep Track Capital, LP3.352.8043.352.8040,0%82.680.14712,09
BlackRock, Inc.2.470.8452.238.934+10,4%60.931.0388,91
RA CAPITAL MANAGEMENT, L.P.2.208.6042.208.6040,0%54.464.1757,96
TCG Crossover Management, LLC1.839.4891.745.015+5,4%45.279.6116,62
Commodore Capital LP1.500.0001.500.0000,0%36.990.0005,41
Caligan Partners LP1.438.0700+100,0%34.628.7265,06
Spruce Street Capital LP1.376.1591.005.593+36,9%33.644.8664,92
JPMORGAN CHASE & CO1.427.5681.611.482-11,4%33.190.9564,85
Trails Edge Capital Partners, LP1.319.3621.395.608-5,5%32.535.4674,76
Nantahala Capital Management, LLC1.052.894675.000+56,0%25.964.3663,80
BALYASNY ASSET MANAGEMENT L.P.923.694896.806+3,0%22.778.2943,33
Logos Global Management LP915.0001.200.000-23,8%22.563.9003,30
VANGUARD CAPITAL MANAGEMENT LLC894.6530+100,0%22.062.1433,22
Alyeska Investment Group, L.P.863.947675.000+28,0%21.283.4993,11
Vivo Capital, LLC800.000800.0000,0%19.728.0002,88
Nan Fung Group Holdings Ltd630.657300.000+110,2%15.552.0022,27
JENNISON ASSOCIATES LLC538.216821.852-34,5%13.272.4061,94
GEODE CAPITAL MANAGEMENT, LLC518.228441.454+17,4%12.783.0991,87
STATE STREET CORP504.373250.030+101,7%12.437.8381,82
CITADEL ADVISORS LLC416.906407.668+2,3%10.280.9021,50

Halter-Trend (6 Quartale)

PeriodeStatusHalterAnteile (Mio)Wert (Mio $)
31.03.2026✓7630,0736
31.12.2025✓6725,1558
30.09.2025✓5321,1328

Top 10 Neueinsteiger

FondsAnteileWert (USD) ⓘ
Trails Edge Capital Partners, LP1.395.60831.066.234
VANGUARD GROUP INC1.112.97824.774.891
Spruce Street Capital LP1.005.59322.384.500
STATE STREET CORP250.0305.565.668
CHARLES SCHWAB INVESTMENT MANAGEMENT INC177.6163.953.732
NORTHERN TRUST CORP143.9663.204.684
HighVista Strategies LLC140.1073.118.782
Longbow Finance SA82.3361.832.799
Nuveen, LLC22.966511.223
Focus Partners Wealth20.095447.315

Top 10 Aufstocker

FondsAnteileΔ Anteile ⓘΔ % ⓘWert (USD) ⓘ
BlackRock, Inc.2.238.9341.263.934+129.6 %49.838.671
JPMORGAN CHASE & CO1.611.482578.879+56.1 %35.871.589
RA CAPITAL MANAGEMENT, L.P.2.208.604431.646+24.3 %49.163.525
GEODE CAPITAL MANAGEMENT, LLC441.454427.863+3148.1 %9.829.858
AMERIPRISE FINANCIAL INC193.544116.094+149.9 %4.308.289
JENNISON ASSOCIATES LLC821.85282.812+11.2 %18.294.425
Logos Global Management LP1.200.00070.000+6.2 %26.712.000
UBS Group AG50.71349.658+4706.9 %1.128.872
BANK OF AMERICA CORP /DE/43.75842.058+2474.0 %974.053
WELLS FARGO & COMPANY/MN22.30321.303+2130.3 %496.465

Top 10 Verkäufer

FondsAnteileΔ Anteile ⓘΔ % ⓘWert (USD) ⓘ
Soleus Capital Management, L.P.10.000-390.000-97.5 %222.600
PRICE T ROWE ASSOCIATES INC /MD/11.074-271.570-96.1 %247
MARSHALL WACE, LLP18.014-237.512-93.0 %400.992
FMR LLC221.865-147.235-39.9 %4.938.715
CITADEL ADVISORS LLC407.668-131.702-24.4 %9.074.690
BALYASNY ASSET MANAGEMENT L.P.896.806-71.468-7.4 %19.962.902
GOLDMAN SACHS GROUP INC303.115-40.408-11.8 %6.747.340
FEDERATED HERMES, INC.5.000-4.000-44.4 %111.300
TWO SIGMA INVESTMENTS, LP12.720-780-5.8 %283.147
Jefferies Financial Group Inc.12.445-655-5.0 %277.026

Zusätzlich aktuell von 2 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →

Aktivisten & Großaktionäre (13D/13G) ⓘ

DatumInvestorTypAnteilAktienΔZweck
15.05.2026Michael KramarzPassiv (13G/A)6,80 %1.972.369+1,30 pp
15.05.2026Robert Egen AtkinsonPassiv (13G/A)6,80 %1.972.369+1,30 pp
15.05.2026Commodore Capital LPPassiv (13G/A)6,80 %1.972.369+1,30 pp
15.05.2026Commodore Capital Master LPPassiv (13G/A)6,80 %1.972.369+1,30 pp
15.05.2026JOHNSON DAVID EDWARDPassiv (13G)5,00 %1.438.070Neu
15.05.2026Caligan Partners LPPassiv (13G)5,00 %1.438.070Neu
15.05.2026TCG Crossover Fund II, L.P.Passiv (13G/A)6,40 %1.839.489-1,40 pp
15.05.2026Chen YuPassiv (13G/A)6,40 %1.839.489-1,40 pp
15.05.2026TCG Crossover GP II, LLCPassiv (13G/A)6,40 %1.839.489-1,40 pp
13.05.2026JPMORGAN CHASE & COPassiv (13G/A)4,90 %1.427.568Neu
17.02.2026Rajeev ShahPassiv (13G/A)8,70 %2.208.604+1,20 pp
17.02.2026RA Capital Healthcare Fund, L.P.Passiv (13G/A)8,70 %2.208.604+1,20 pp
17.02.2026Peter KolchinskyPassiv (13G/A)8,70 %2.208.604+1,20 pp
17.02.2026RA Capital Management, L.P.Passiv (13G/A)8,70 %2.208.604+1,20 pp
10.02.2026Deep Track Special Opportunities Fund, LPAktivist (13D/A)2,30 %666.666-0,70 ppItem 4 of the Schedule 13D is hereby amended and supplemented as follows: On February 4…
10.02.2026David KroinAktivist (13D/A)11,70 %3.352.804-3,20 ppItem 4 of the Schedule 13D is hereby amended and supplemented as follows: On February 4…
10.02.2026Deep Track Biotechnology Master Fund, Ltd.Aktivist (13D/A)9,40 %2.686.138-2,60 ppItem 4 of the Schedule 13D is hereby amended and supplemented as follows: On February 4…
10.02.2026Deep Track Capital, LPAktivist (13D/A)11,70 %3.352.804-3,20 ppItem 4 of the Schedule 13D is hereby amended and supplemented as follows: On February 4…
21.01.2026BlackRock Portfolio Management LLCPassiv (13G/A)3,80 %961.158-2,10 pp
21.01.2026BlackRock, Inc.Passiv (13G)5,10 %1.277.776Neu
21.01.2026JPMORGAN CHASE & CO.Passiv (13G)6,30 %1.611.482Neu
31.12.2025Trails Edge Capital Partners, LPPassiv (13G)5,00 %1.268.265Neu
31.12.2025Ortav YehudaiPassiv (13G)5,00 %1.268.265Neu
31.12.2025Trails Edge Biotechnology Master Fund, LPPassiv (13G)5,00 %1.268.265Neu
17.10.2025BlackRock Portfolio Management LLCPassiv (13G)5,90 %975.000Neu
25.09.2025Pontifax Management 4 G.P. (2015) Ltd.Aktivist (13D)6,30 %1.411.681NeuThe Reporting Persons acquired the securities reported herein for investment purposes, s…
25.09.2025Ran NussbaumAktivist (13D)6,30 %1.411.681NeuThe Reporting Persons acquired the securities reported herein for investment purposes, s…
25.09.2025Pontifax VI G.P. L.P.Aktivist (13D)6,30 %1.411.681NeuThe Reporting Persons acquired the securities reported herein for investment purposes, s…
25.09.2025Tomer KarivAktivist (13D)6,30 %1.411.681NeuThe Reporting Persons acquired the securities reported herein for investment purposes, s…
19.09.2025Peter KolchinskyPassiv (13G)7,50 %1.675.000Neu
19.09.2025RA Capital Healthcare Fund, L.P.Passiv (13G)7,50 %1.675.000Neu
19.09.2025RA Capital Management, L.P.Passiv (13G)7,50 %1.675.000Neu
19.09.2025Rajeev ShahPassiv (13G)7,50 %1.675.000Neu
19.09.2025Deep Track Capital, LPAktivist (13D)14,90 %3.352.804NeuThe Reporting Persons acquired the securities reported herein for investment purposes, s…
19.09.2025Deep Track Special Opportunities Fund, LPAktivist (13D)3,00 %666.666NeuThe Reporting Persons acquired the securities reported herein for investment purposes, s…
19.09.2025Deep Track Biotechnology Master Fund, Ltd.Aktivist (13D)12,00 %2.686.138NeuThe Reporting Persons acquired the securities reported herein for investment purposes, s…
19.09.2025David KroinAktivist (13D)14,90 %3.352.804NeuThe Reporting Persons acquired the securities reported herein for investment purposes, s…
18.09.2025Michael KramarzPassiv (13G)5,50 %1.225.000Neu
18.09.2025Commodore Capital Master LPPassiv (13G)5,50 %1.225.000Neu
18.09.2025Robert Egen AtkinsonPassiv (13G)5,50 %1.225.000Neu

Stammdaten

Biopharmaunternehmen in klinischer Phase, das neuartige Therapien für neuropsychiatrische Erkrankungen entwickelt (z.B. Schizophrenie, bipolare Depression). Leitkandidat ist LB-102, ein methyliertes Derivat von Amisulprid.

Unternehmen & Branche

NameLB PHARMACEUTICALS INC
TickerLBRX
CIK0001691082
BoerseNasdaq
SektorHealthcare
IndustrieBiotechnology
SIC2834 · Pharmaceutical Preparations

Wertpapier & Kennzahlen

CUSIP50180M108
ISINUS50180M1080
TypCommon Stock
Marktkapitalisierung719,0 Mio. USD

Bewertung

KBV (P/B)2,39
FCF-Rendite-4,9 %

Qualität & Bilanz

ROIC-8,3 %

Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2024. Kennzahlen erklärt →

Externe Quelle: SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »

Finanzkennzahlen (SEC XBRL) ⓘ

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2026-03-3110-Q-19.054.000-0,67393.482.000378.693.000
2025-12-3110-K-25.205.000-3,13312.934.000301.310.000
2025-09-3010-Q-3.556.000-0,61320.746.000310.221.000
2025-06-3010-Q-4.870.000-103.873.000
2025-03-3110-Q-5.307.000-14,79-99.338.000
2024-12-3110-K-63.102.000-176,1533.534.000-94.554.000
2024-09-3010-Q-14.181.000-39,49-91.450.000
2024-06-3010-Q-27.632.000-77.443.000
2024-03-3110-Q-16.218.000-50.446.000

Quartalsergebnisse (Earnings) ⓘ

QuartalStichtagVerkündetUmsatzEPS
Q1 202631.03.202612.05.2026–-0,67
Q3 202530.09.202506.11.2025–-0,61
Q1 202531.03.202512.05.2026–-14,79
Q3 202430.09.202406.11.2025–-39,49

Einreichungs-Historie (10-K / 10-Q)

SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte (10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die Tage zwischen Berichtsstichtag und tatsächlicher Einreichung. Suffix /A kennzeichnet nachträgliche Berichtigungen.

Eingereicht Form Berichtsperiode Verzögerung
12.05.2026 10-Q – – SEC »
26.03.2026 10-K 31.12.2025 85 Tage SEC »
06.11.2025 10-Q 30.09.2025 37 Tage SEC »

Fail-to-Deliver (6 Monate) ⓘ

DatumFTD-MengeKursWert (USD)
2026-05-281327,80361
2026-05-2619.90028,12559.588
2026-05-2120028,035.606
2026-05-052931,83923
2026-04-2819931,816.330
2026-04-2730130,739.250
2026-04-2479830,7824.562
2026-04-2143331,6713.713
2026-04-174.33028,28122.452
2026-04-169729,122.825
2026-04-156726,571.780
2026-04-135524,341.339
2026-04-1041026,2910.779
2026-04-0934625,988.989
2026-04-075326,941.428
2026-04-026624,811.637
2026-03-311.20023,2527.900
2026-03-3024123,845.745
2026-03-237523,531.765
2026-03-061.22523,5528.849
2026-03-031.23123,7829.273
2026-03-021.11024,0126.651
2026-02-273.77324,2391.420
2026-02-1914424,023.459
2026-02-1812.82224,12309.267
2026-02-174923,341.144
2026-02-136624,351.607
2026-02-115024,221.211
2026-02-091.84123,8243.853
2026-02-0520021,174.234
2026-02-0314.46522,91331.393
2026-01-2824222,535.452
2026-01-273.18522,3871.280
2026-01-213.23721,5669.790
2026-01-132.42319,0346.110
2026-01-062.60320,5653.518
2026-01-053.89620,4479.634
2025-12-312.02321,5043.495
2025-12-304.51421,4096.600
2025-12-293.96521,5385.366
2025-12-2675.53322,001.661.726
2025-12-24117.41722,152.600.787
2025-12-2390.98822,542.050.870
2025-12-2250.68621,071.067.954
2025-12-174.79519,8295.037
2025-12-162.88819,8657.356

Hinweis

Erweitert ×